Marc E. Gillespie, Ph.D.

Senior Vice Provost for Clinical Operations, Graduate Research, Assessment, Accreditation, and Institutional Analytics
Newman Hall 230 G
[email protected]

Dr. Gillespie is the Senior Vice Provost for Clinical Operations, Graduate Research, Assessment, Accreditation, and Institutional Analytics, and serves as a senior staff member in the Office of the Provost. As Sr. Vice Provost, he leads Institutional Effectiveness (IE), encompassing Assessment and Accreditation, Institutional Research, and Data Science. IE aligns St. John’s University data arms with the University assessment and accreditation operations to ensure that our collective priorities are executed in a strategic manner. 

He earned his doctorate in Oncological Sciences from the University of Utah in 1998, was a research fellow at Memorial Sloan Kettering Cancer Center, and joined St. John’s faculty in the Department of Pharmaceutical SciencesCollege of Pharmacy and Health Sciences, in 2000. Dr. Gillespie steered successful professional program accreditation self-study reports, chaired, and led college-wide assessment. In 2017, he became the Associate Dean of Graduate Education, Research, and Assessment in the College of Pharmacy and Health Sciences, developing statistical approaches to student performance prediction, accreditation, program development, and curriculum assessment. 

Dr. Gillespie currently chairs the University’s Institutional Biosafety Committee and Graduate Council, and is Cochair of the University Assessment Committee. In addition, he created and directs the University’s Clinical Venture Laboratory, a New York State Department of Health Clinical Laboratory Improvement Amendments-compliant laboratory. 

He is a molecular biologist, bioinformaticist, and toxicologist, leading a research group working in pharmacogenomics biomarker discovery. He has published more than 150 research papers on topics including molecular toxicology, RNA biology, and SARS-CoV-2 pathway curation, and is an Adjunct Professor in the Department of Biochemistry and Molecular Pharmacology at the NYU Langone Health New York University Grossman School of Medicine. Dr. Gillespie is also a Biocurator and Editor on the Reactome project, an open-source, open-access, manually curated, and peer-reviewed biological pathway database supported by the National Institutes of Health and the European Molecular Biology Laboratory.  

He leads a research group focused on toxicogenomics, bioinformatics, and biomarker discovery and has taught courses in pharmacogenomics, public health, human anatomy and physiology, toxicogenomics, and molecular biology. He has experience in academia and industry regarding public health policy.